Literature DB >> 18005233

Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice.

L A Snyder1, K A Rudnick, R Tawadros, A Volk, S H Tam, G M Anderson, P J Bugelski, J Yang.   

Abstract

BACKGROUND: Tissue factor (TF) is expressed widely at the subluminal surface of blood vessels and serves as the primary cellular initiator of the extrinsic pathway of blood coagulation. Lack of TF in mice resulted in lethality in utero, but human TF (huTF) expressed at low levels from a human minigene rescued null mice from prenatal death. Although these low-TF expressing transgenic mice developed to term, they had a significantly shorter life span and exhibited hemorrhage and fibrosis in the heart.
METHODS: Human TF knock-in (TFKI) mice were generated by replacing the first two exons of the mouse (murine) TF (muTF) gene with the huTF complete coding sequence, thus placing it under the control of the endogenous muTF promoter.
RESULTS: Expression of huTF in the TFKI mice was similar to muTF in wild-type (wt) mice. The TFKI mice showed no microscopic evidence of spontaneous hemorrhage in the heart, nor cardiac fibrosis at up to 18 months of age. Immunohistochemistry showed that huTF was expressed in cells surrounding blood vessels in TFKI mice. Coagulation activity of brain homogenates from TFKI mice was comparable with that from wt brain. Cardiac hemorrhage similar to that of the low-TF transgenic mice occurred in the TFKI mice when huTF was blocked by a neutralizing anti-huTF monoclonal antibody.
CONCLUSION: We generated a transgenic mouse line that expresses huTF under the control of the endogenous muTF promoter at physiological levels. Our results suggest that huTF can fully reconstitute the murine coagulation system and mediate normal hemostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005233     DOI: 10.1111/j.1538-7836.2007.02833.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

1.  Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.

Authors:  Christoph Reinhardt; Mattias Bergentall; Thomas U Greiner; Florence Schaffner; Gunnel Ostergren-Lundén; Lars C Petersen; Wolfram Ruf; Fredrik Bäckhed
Journal:  Nature       Date:  2012-03-11       Impact factor: 49.962

2.  Bleeding hearts.

Authors:  Nigel Mackman
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

Review 3.  Tissue factor and PAR2 signaling in the tumor microenvironment.

Authors:  Florence Schaffner; Wolfram Ruf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

4.  Human thrombomodulin knock-in mice reveal differential effects of human thrombomodulin on thrombosis and atherosclerosis.

Authors:  Thomas J Raife; Denis M Dwyre; Jeff W Stevens; Rochelle A Erger; Lorie Leo; Katina M Wilson; Jose A Fernández; Jennifer Wilder; Hyung-Suk Kim; John H Griffin; Nobuyo Maeda; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

5.  Tissue factor in cancer progression and angiogenesis.

Authors:  Wolfram Ruf; Naho Yokota; Florence Schaffner
Journal:  Thromb Res       Date:  2010-04       Impact factor: 3.944

Review 6.  Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.

Authors:  J Boles; N Mackman
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

7.  Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.

Authors:  Yuichi Kamikubo; G Loredana Mendolicchio; Antonella Zampolli; Patrizia Marchese; Andrea S Rothmeier; Jennifer Nagrampa Orje; Andrew J Gale; Sriram Krishnaswamy; András Gruber; Henrik Østergaard; Lars C Petersen; Wolfram Ruf; Zaverio M Ruggeri
Journal:  Blood       Date:  2017-07-20       Impact factor: 22.113

8.  Tissue factor and heart inflammation.

Authors:  R Pawlinski; N Mackman
Journal:  J Thromb Haemost       Date:  2009-02       Impact factor: 5.824

Review 9.  Triggers, targets and treatments for thrombosis.

Authors:  Nigel Mackman
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

10.  PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation.

Authors:  Xiaolin He; Bing Han; Xiaohui Bai; Yu Zhang; Marcelo Cypel; Marco Mura; Shaf Keshavjee; Mingyao Liu
Journal:  Intensive Care Med       Date:  2009-11-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.